UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 92

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Height, weight, and motor–social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy

Human reproduction (Oxford), 2004-06, Vol.19 (6), p.1323-1330

2004

Volltextzugriff (PDF)

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

Human reproduction (Oxford), 2002-11, Vol.17 (11), p.2858-2864

2002

Volltextzugriff (PDF)

Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome

Journal of Pediatric Endocrinology and Metabolism, 2006-06, Vol.19 (6), p.831

2006

Volltextzugriff (PDF)

Enoxaparin prevents progression of stages I and II osteonecrosis of the hip

Clinical orthopaedics and related research, 2005-06 (435), p.164-170

2005

Volltextzugriff (PDF)

A Commentary on: "Neural overlap in processing music and speech"

Frontiers in human neuroscience, 2015-06, Vol.9, p.330-330

2015

Volltextzugriff (PDF)

20 PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY, 4G5G POLYMORPHISM OF THE PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) GENE, AND FIRST-TRIMESTER MISCARRIAGE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME

Journal of investigative medicine, 2006-03, Vol.54 (2), p.S376-S376

2006

Volltextzugriff (PDF)

21 GROWTH, MOTOR, AND SOCIAL DEVELOPMENT IN BREAST- AND FORMULA-FED INFANTS OF METFORMIN-TREATED WOMEN WITH POLYCYSTIC OVARY SYNDROME

Journal of investigative medicine, 2006-03, Vol.54 (2), p.S376-S376

2006

Volltextzugriff (PDF)

56 PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY DURING PREGNANCY IN 43 WOMEN WITH POLYCYSTIC OVARY SYNDROME, 21 WITH LIVE BIRTHS, 22 WITH MISCARRIAGES

Journal of investigative medicine, 2005-03, Vol.53 (2), p.S396-S396

2005

Volltextzugriff (PDF)

22 CHANGES IN WEIGHT, PAPILLEDEMA, HEADACHE, VISUAL FIELD, AND LIFE STATUS IN RESPONSE TO DIET AND METFORMIN IN WOMEN WITH IDIOPATHIC INTRACRANIAL HYPERTENSION

Journal of investigative medicine, 2006-03, Vol.54 (2), p.S376-S376

2006

Volltextzugriff (PDF)

61 AMAUROSIS FUGAX CAUSED BY THROMBOPHILIA-HYPOFIBRINOLYSIS IN CASES WITHOUT CAROTID ATHEROSCLEROSIS: THERAPY WITH COUMADIN-LOVENOX OR FOLIC ACID-B6-B12 PREVENTS SUBSEQUENT TRANSIENT MONOCULAR PARTIAL BLINDNESS

Journal of investigative medicine, 2005-03, Vol.53 (2), p.S397-S397

2005

Volltextzugriff (PDF)

58 THE PREVALENCE OF 4G5G POLYMORPHISM OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) GENE IN POLYCYSTIC OVARIAN SYNDROME AND ITS ASSOCIATION WITH PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY LEVELS

Journal of investigative medicine, 2005-03, Vol.53 (2), p.S397-S397

2005

Volltextzugriff (PDF)

4 SUCCESS OF METFORMIN-PIOGLITAZONE IN RESOLVING ENDOCRINOPATHY AND INSULIN RESISTANCE-HYPERINSULINEMIA IN 40 WOMEN WITH POLYCYSTIC OVARY SYNDROME NOT OPTIMALLY RESPONSIVE TO METFORMIN ALONE

Journal of investigative medicine, 2006-03, Vol.54 (2), p.S373-S373

2006

Volltextzugriff (PDF)

74 METFORMIN-DIET AMELIORATES CORONARY HEART DISEASE RISK FACTORS AND FACILITATES RESUMPTION OF REGULAR MENSES IN ADOLESCENTS WITH POLYCYSTIC OVARY SYNDROME

Journal of investigative medicine, 2006-03, Vol.54 (2), p.S386-S386

2006

Volltextzugriff (PDF)

2 WEIGHT LOSS IS A FEATURE OF PROTRACTED METFORMIN THERAPY IN WOMEN WITH POLYCYSTIC OVARY SYNDROME

Journal of investigative medicine, 2006-03, Vol.54 (2), p.S373-S373

2006

Volltextzugriff (PDF)

59 THROMBOPHILIA AND HYPOFIBRINOLYSIS: REVERSIBLE RISK FACTORS FOR OSTEONECROSIS OF THE FEMORAL HEAD IN ADULTS

Journal of investigative medicine, 2005-03, Vol.53 (2), p.S397-S397

2005

Volltextzugriff (PDF)

57 CHANGES IN PAPILLEDEMA, HEADACHE, AND LIFE STATUS IN RESPONSE TO DIET AND METFORMIN IN WOMEN WITH IDIOPATHIC INTRACRANIAL HYPERTENSION WITH AND WITHOUT CONCURRENT POLYCYSTIC OVARY SYNDROME OR HYPERINSULINEMIA

Journal of investigative medicine, 2005-03, Vol.53 (2), p.S396-S397

2005

Volltextzugriff (PDF)

10 IDIOPATHIC INTRACRANIAL HYPERTENSION, POLYCYSTIC OVARY SYNDROME, AND THROMBOPHILIA

Journal of investigative medicine, 2005-03, Vol.53 (2), p.S388-S388

2005

Volltextzugriff (PDF)

Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome

Metabolism, clinical and experimental, 2006-03, Vol.55 (3), p.345-352

2006

Volltextzugriff (PDF)

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

Human reproduction (Oxford), 2003-08, Vol.18 (8), p.1618-1625

2003

Volltextzugriff (PDF)

48 HEIGHT, WEIGHT, MOTOR AND SOCIAL DEVELOPMENT DURING THE FIRST YEAR OF LIFE IN INFANTS BORN TO 108 MOTHERS WITH POLYCYSTIC OVARY SYNDROME WHO CONCEIVED ON AND CONTINUED METFORMIN THROUGH PREGNANCY

Journal of investigative medicine, 2004-03, Vol.52 (Suppl 2), p.S385-S385

2004

Volltextzugriff (PDF)

33 IDIOPATHIC INTRACRANIAL HYPERTENSION: ASSOCIATIONS WITH COAGULATION DISORDERS AND POLYCYSTIC OVARY SYNDROME

Journal of investigative medicine, 2004-03, Vol.52 (Suppl 2), p.S382-S382

2004

Volltextzugriff (PDF)

8 METFORMIN DURING PREGNANCY REDUCES INSULIN, INSULIN RESISTANCE, INSULIN SECRETION, WEIGHT, TESTOSTERONE, AND DEVELOPMENT OF GESTATIONAL DIABETES: PROSPECTIVE LONGITUDINAL STUDY OF WOMEN WITH POLYCYSTIC OVARY SYNDROME FROM PRE-CONCEPTION THROUGH PREGNANCY

Journal of investigative medicine, 2004-03, Vol.52 (Suppl 2), p.S378-S378

2004

Volltextzugriff (PDF)

21 IDIOPATHIC INTRACRANIAL HYPERTENSION: ASSOCIATIONS WITH COAGULATION DISORDERS IN MEN

Journal of investigative medicine, 2004-03, Vol.52 (Suppl 2), p.S349-S349

2004

Volltextzugriff (PDF)

19 PREGNANCY LOSS, POLYCYSTIC OVARY SYNDROME, THROMBOPHILIA, HYPOFIBRINOLYSIS, LOW MOLECULAR WEIGHT HEPARIN

Journal of investigative medicine, 2004-03, Vol.52 (Suppl 2), p.S349-S349

2004

Volltextzugriff (PDF)

Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy

European journal of obstetrics & gynecology and reproductive biology, 2005-10, Vol.122 (2), p.206-212

2005

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(38)
Humans
(37)
Biological And Medical Sciences
(34)
Female
(34)
Medical Sciences
(31)
Adult
(19)
Male
(19)
Middle Aged
(15)
Risk Factors
(13)
Polycystic Ovary Syndrome - Complications
(12)
Aged
(11)
Endocrinology & Metabolism
(11)
Metformin - Therapeutic Use
(11)
Pregnancy
(10)
Adolescent
(9)
Pharmacology. Drug Treatments
(9)
Polycystic Ovary Syndrome - Drug Therapy
(9)
Prospective Studies
(9)
Polycystic Ovary Syndrome
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Height, weight, and motor–social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome

Enoxaparin prevents progression of stages I and II osteonecrosis of the hip

A Commentary on: "Neural overlap in processing music and speech"

20 PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY, 4G5G POLYMORPHISM OF THE PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) GENE, AND FIRST-TRIMESTER MISCARRIAGE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME

21 GROWTH, MOTOR, AND SOCIAL DEVELOPMENT IN BREAST- AND FORMULA-FED INFANTS OF METFORMIN-TREATED WOMEN WITH POLYCYSTIC OVARY SYNDROME

56 PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY DURING PREGNANCY IN 43 WOMEN WITH POLYCYSTIC OVARY SYNDROME, 21 WITH LIVE BIRTHS, 22 WITH MISCARRIAGES

22 CHANGES IN WEIGHT, PAPILLEDEMA, HEADACHE, VISUAL FIELD, AND LIFE STATUS IN RESPONSE TO DIET AND METFORMIN IN WOMEN WITH IDIOPATHIC INTRACRANIAL HYPERTENSION

61 AMAUROSIS FUGAX CAUSED BY THROMBOPHILIA-HYPOFIBRINOLYSIS IN CASES WITHOUT CAROTID ATHEROSCLEROSIS: THERAPY WITH COUMADIN-LOVENOX OR FOLIC ACID-B6-B12 PREVENTS SUBSEQUENT TRANSIENT MONOCULAR PARTIAL BLINDNESS

58 THE PREVALENCE OF 4G5G POLYMORPHISM OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) GENE IN POLYCYSTIC OVARIAN SYNDROME AND ITS ASSOCIATION WITH PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY LEVELS

4 SUCCESS OF METFORMIN-PIOGLITAZONE IN RESOLVING ENDOCRINOPATHY AND INSULIN RESISTANCE-HYPERINSULINEMIA IN 40 WOMEN WITH POLYCYSTIC OVARY SYNDROME NOT OPTIMALLY RESPONSIVE TO METFORMIN ALONE

74 METFORMIN-DIET AMELIORATES CORONARY HEART DISEASE RISK FACTORS AND FACILITATES RESUMPTION OF REGULAR MENSES IN ADOLESCENTS WITH POLYCYSTIC OVARY SYNDROME

2 WEIGHT LOSS IS A FEATURE OF PROTRACTED METFORMIN THERAPY IN WOMEN WITH POLYCYSTIC OVARY SYNDROME

59 THROMBOPHILIA AND HYPOFIBRINOLYSIS: REVERSIBLE RISK FACTORS FOR OSTEONECROSIS OF THE FEMORAL HEAD IN ADULTS

57 CHANGES IN PAPILLEDEMA, HEADACHE, AND LIFE STATUS IN RESPONSE TO DIET AND METFORMIN IN WOMEN WITH IDIOPATHIC INTRACRANIAL HYPERTENSION WITH AND WITHOUT CONCURRENT POLYCYSTIC OVARY SYNDROME OR HYPERINSULINEMIA

10 IDIOPATHIC INTRACRANIAL HYPERTENSION, POLYCYSTIC OVARY SYNDROME, AND THROMBOPHILIA

Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

48 HEIGHT, WEIGHT, MOTOR AND SOCIAL DEVELOPMENT DURING THE FIRST YEAR OF LIFE IN INFANTS BORN TO 108 MOTHERS WITH POLYCYSTIC OVARY SYNDROME WHO CONCEIVED ON AND CONTINUED METFORMIN THROUGH PREGNANCY

33 IDIOPATHIC INTRACRANIAL HYPERTENSION: ASSOCIATIONS WITH COAGULATION DISORDERS AND POLYCYSTIC OVARY SYNDROME

8 METFORMIN DURING PREGNANCY REDUCES INSULIN, INSULIN RESISTANCE, INSULIN SECRETION, WEIGHT, TESTOSTERONE, AND DEVELOPMENT OF GESTATIONAL DIABETES: PROSPECTIVE LONGITUDINAL STUDY OF WOMEN WITH POLYCYSTIC OVARY SYNDROME FROM PRE-CONCEPTION THROUGH PREGNANCY

21 IDIOPATHIC INTRACRANIAL HYPERTENSION: ASSOCIATIONS WITH COAGULATION DISORDERS IN MEN

19 PREGNANCY LOSS, POLYCYSTIC OVARY SYNDROME, THROMBOPHILIA, HYPOFIBRINOLYSIS, LOW MOLECULAR WEIGHT HEPARIN

Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy

Suchergebnisse filtern